AEON Biopharma

AEONNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$13.538 M

$0.28 -1.91%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$39.2M

Loss-making

Shares outstanding

25,303,058

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#419Chemomab TherapeuticsCMMB$13.9M
#420Palatin TechnologiesPTN$13.8M
#421AEON BiopharmaAEON$13.5M
#422Psyence BiomedicalPBM$13.2M
#423Vistagen TherapeuticsVTGN$12.8M

Where these numbers come from

Share counts and financials for AEON Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.